Pfizer Interested in Purchasing Seagen for $30 Billion
Biotech company Seagen, which focuses on cancer treatments, could soon have a new owner even after the failed sale to pharmaceutical giant Merck. According to the Wall Street Journal, Pfizer, one of the world’s leading pharma companies, engaged in early talks about the Seagen...